Experts Push for Earlier Kidney Disease Screening

New approaches aim to catch kidney disease sooner to improve long-term outcomes for patients.

Updated on Oct. 29, 2026 in Diabetes

A clear medical glass beaker sits on a sterile white lab surface, representing the focus on precision diagnostic testing. — The American Society of Nephrology is calling for more robust, early-stage screening protocols to improve outcomes for patients with chronic kidney disease. AI Illustration. Upload story photo >

Live Poll

Should the government implement mandatory national screening programs for chronic kidney disease?

Experts at the American Society of Nephrology meeting are calling for improved early detection methods for chronic kidney disease in the United States. Current clinical practice lacks routine screening protocols for asymptomatic individuals, leaving many patients undiagnosed until advanced stages.

Why it matters

Earlier detection is critical for patients to benefit from new therapeutic options before reaching end-stage kidney disease. Currently, routine urine testing for healthy patients is not part of standard medical guidelines, leading to significant delays in care.

Industry experts report a 17-year gap between clinical evidence and routine practice uptake for SGLT2 inhibitors. It remains unknown when new biomarker or AI-driven screening protocols will be officially integrated into national clinical guidelines.

The players

American Society of Nephrology

A professional medical organization that sets standards for kidney care and advances research into nephrology treatments.

The details

Chronic kidney disease is often asymptomatic until it reaches advanced stages, making current diagnostic reliance on nephrologist-led biopsies for rare glomerular diseases like IgA nephropathy inefficient. Researchers are proposing a shift toward precision medicine, leveraging big data, AI, and novel biomarkers to identify high-risk individuals earlier. These tools aim to monitor treatment responses more dynamically and facilitate the use of advanced therapies before irreversible damage occurs.

October 2026: Experts discussed kidney health strategies at the American Society of Nephrology Kidney Week meeting.

Health Landscape

Current management of kidney health follows a traditional model that frequently misses early disease onset due to the absence of targeted screening. This proposed shift toward precision medicine marks a departure from standard guidelines that currently only prioritize biopsy-based diagnostics.

Because chronic kidney disease remains asymptomatic for years, it is worth discussing your personal risk factors for kidney damage with your primary care physician. Ask your doctor if your health history warrants specialized monitoring, as routine screenings for the condition are not currently standard.

The takeaway

Early detection remains the most effective tool to prevent end-stage kidney failure, yet current testing is rarely proactive for asymptomatic patients. Individuals should consult with their doctor about their kidney function, especially if they have risk factors like high blood pressure or diabetes.